CIB2是心房重构的新型内源性抑制因子
本研究通过RNA测序发现CIB2是心房富集蛋白,在房颤患者和房颤小鼠模型左心房中显著下调。利用心肌细胞特异性敲除和过表达小鼠模型,证实CIB2缺失增强房颤发生与持续时间并加重心房纤维化,而过表达则减轻血管紧张素II诱导的房颤和纤维化。机制上CIB2竞争性抑制CIB1介导的钙调磷酸酶激活,从而对抗应激性结构重构和房颤。
要点
- CIB2是心房富集蛋白,在房颤患者和房颤小鼠模型左心房中显著下调
- CIB2缺失增强房颤发生、延长持续时间并加重应激下心房纤维化
- CIB2过表达减轻血管紧张素II诱导的房颤和心房纤维化
核心结论
- CIB2是新型内源性心房富集调节因子,在应激条件下保护免受心房重构和房颤。
- CIB2可能成为治疗房颤的新潜在靶点。
研究设计与样本
- 研究采用RNA测序分析识别心房肌细胞特异性和血管紧张素II响应基因。
- 构建了心肌细胞特异性敲除和心房肌细胞特异性过表达的遗传修饰小鼠模型。
- 进行了体内和体外电生理、组织学和生化分析以确定CIB2功能获得和丧失的后果。
主要发现
- CIB2在房颤患者左心房和血管紧张素II输注或压力过载房颤小鼠模型的左心房中显著下调。
- CIB2敲除小鼠显示房颤发生增强、房颤持续时间延长,并与应激下心房纤维化显著增加相关。
- CIB2过表达减轻血管紧张素II应激诱导的房颤发生和心房纤维化。
- 机制上CIB2竞争并抑制CIB1介导的钙调磷酸酶激活,从而抵消应激诱导的结构重构和房颤。
临床怎么用
- CIB2可作为房颤治疗的新潜在靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial fibrillation (AF) is a highly prevalent condition that can cause or exacerbate heart failure, is an important risk factor for stroke, and is associated with pronounced morbidity and death. Genes uniquely expressed in the atria are known to be essential for maintaining atrial structure and function. Atrial tissue remodeling contributes to arrhythmia recurrence and maintenance. However, the mechanism underlying atrial remodeling remains poorly understood. This study was designed to investigate whether other uncharacterized atrial specific genes play important roles in atrial physiology and arrhythmogenesis. METHODS: RNA-sequencing analysis was used to identify atrial myocyte specific and angiotensin II-responsive genes. Genetically modified, cardiomyocyte-specific mouse models (knockout and overexpression) were generated. In vivo and in vitro electrophysiological, histology, and biochemical analyses were performed to determine the consequences of CIB2 (calcium and integrin binding family member 2 protein) gain and loss of function in the atrium. RESULTS: Using RNA-sequencing analysis, we identified CIB2 as an atrial-enriched protein that is significantly downregulated in the left atria of patients with AF and mouse models of AF from angiotensin II infusion or pressure overload. Using cardiomyocyte-specific Cib2 knockout (Cib2-/-) and atrial myocyte-specific Cib2-overexpressing mouse models, we found that loss of Cib2 enhances AF occurrence, prolongs AF duration, and correlates with a significant increase in atrial fibrosis under stress. Conversely, Cib2 overexpression mitigates AF occurrence and atrial fibrosis triggered by angiotensin II stress. Mechanistically, we revealed that CIB2 competes with and inhibits CIB1-mediated calcineurin activation, thereby negating stress-induced structural remodeling and AF. CONCLUSIONS: Our data suggest that CIB2 represents a novel endogenous and atrial-enriched regulator that protects against atrial remodeling and AF under stress conditions. Therefore, CIB2 may represent a new potential target for treating AF.
引用
- Wang Y, Wang J, Shi L, et al. CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling. Circulation. 2023. PMID: 37128899. doi:10.1161/CIRCULATIONAHA.122.062660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。